Standardized mean differences of covariates used to match belatacept and CNI at transplant in the matched cohort.
figure
posted on 2025-01-10, 20:09 authored by Wida S. Cherikh, Tzuyung Douglas Kou, Julia Foutz, Timothy J. Baker, Andres Gomez-CamineroaUsing imputed value for missing. bRefers to rabbit-derived antithymocyte globulin (Thymoglobulin). c“Region” refers to observations with overlapping propensity scores for the treated (belatacept) and control (CNI) groups. BMI, body mass index; CMV, cytomegalovirus; CNI, calcineurin inhibitor; EBV, Epstein-Barr virus.
(TIF)
History
Usage metrics
Categories
Keywords
transplant lymphoproliferative disorderroutine clinical practicekaplan &# 8211describe patient characteristicscentral nervous system2016 ), 942011 &# 8211xlink "> datatransplant recipients treatedreceived basiliximab inductionknown ebv serostatusestimated ptld incidence48 %, respectivelyxlink "> belataceptcns involvement ).xlink ">us foodtreatment groupstransplantation networksignificantly differentremained lowptld developedorgan rejectionorgan procurementjune 15june 14group differencedrug administrationdied duecalcineurin inhibitorbelatacept usebased immunosuppressionbarr virusamong ebv18 ).
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC